ICD-10-CM Billable Code

F14.280

Cocaine dependence with cocaine-induced anxiety disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

Cocaine dependence with cocaine-induced anxiety disorder is a mental health condition characterized by a compulsive need to use cocaine, accompanied by anxiety symptoms directly linked to cocaine use. This condition reflects both a substance use disorder and an anxiety component triggered or exacerbated by cocaine consumption. Understanding this disorder involves recognizing its causes, symptoms, ways it is diagnosed, and treatment options.

Causes & Symptoms

Clinical Causes: Chronic use of cocaine leading to neurochemical changes in the brain's reward and anxiety pathways. Genetic predisposition influencing susceptibility to substance dependence and anxiety disorders. Psychological factors such as stress, trauma, or mental health history that increase the risk of substance use and anxiety. Environmental influences including peer pressure, socio-economic factors, and availability of cocaine. Repeated exposure to cocaine resulting in neuroadaptations that promote dependence and anxiety symptoms.

Key Symptoms: Strong cravings for cocaine Persistent thoughts about obtaining and using cocaine Loss of control over cocaine use Anxiety, nervousness, or restlessness during or following cocaine use Physical signs such as dilated pupils, increased heart rate, and elevated blood pressure Mood swings or agitation Sleep disturbances like insomnia or restless sleep Episodes of panic or intense worry associated with cocaine use Negative impact on daily functioning such as difficulty concentrating or maintaining relationships

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment by a healthcare professional. The evaluator reviews the individual's substance use history, mental health symptoms, and any related behaviors. Specific criteria include evidence of dependence on cocaine and observed or reported anxiety symptoms tied to its use. Laboratory tests like toxicology screens may be used to confirm recent cocaine intake. Mental health assessments are also conducted to distinguish cocaine-induced anxiety from primary anxiety disorders, ensuring accurate diagnosis.

Treatment Protocols: Behavioral therapies such as cognitive-behavioral therapy (CBT) to modify thoughts and behaviors related to cocaine use and manage anxiety. Motivational interviewing to enhance motivation for recovery. Medication-assisted treatment may include medications to ease withdrawal symptoms or reduce cravings, although no specific medications are approved solely for cocaine dependence. Monitoring and managing anxiety symptoms through counseling, relaxation techniques, or medications as appropriate. Support groups and counseling programs to provide ongoing support and relapse prevention. Addressing co-occurring mental health conditions to create a comprehensive treatment plan.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F14.280 a billable ICD-10 code?
Yes, F14.280 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F14.280?
Clinical documentation must specify the nature of Cocaine dependence with cocaine-induced anxiety disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference